Global Insertable Heart Monitors Market Growth 2025-2031
Description
The global Insertable Heart Monitors market size is predicted to grow from US$ 729 million in 2025 to US$ 1123 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient"s heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart"s ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
LP Information, Inc. (LPI) ' newest research report, the “Insertable Heart Monitors Industry Forecast” looks at past sales and reviews total world Insertable Heart Monitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Insertable Heart Monitors sales for 2025 through 2031. With Insertable Heart Monitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insertable Heart Monitors industry.
This Insight Report provides a comprehensive analysis of the global Insertable Heart Monitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insertable Heart Monitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insertable Heart Monitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insertable Heart Monitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insertable Heart Monitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Insertable Heart Monitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Implantation Loop Recorder (ILR)
Insertable Cardiac Monitor (ICM)
Segmentation by Application:
Medical
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Vectorious
LivaNova
Phoenix Heart
Angel Medical Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insertable Heart Monitors market?
What factors are driving Insertable Heart Monitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insertable Heart Monitors market opportunities vary by end market size?
How does Insertable Heart Monitors break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient"s heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart"s ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
LP Information, Inc. (LPI) ' newest research report, the “Insertable Heart Monitors Industry Forecast” looks at past sales and reviews total world Insertable Heart Monitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Insertable Heart Monitors sales for 2025 through 2031. With Insertable Heart Monitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insertable Heart Monitors industry.
This Insight Report provides a comprehensive analysis of the global Insertable Heart Monitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insertable Heart Monitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insertable Heart Monitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insertable Heart Monitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insertable Heart Monitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Insertable Heart Monitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Implantation Loop Recorder (ILR)
Insertable Cardiac Monitor (ICM)
Segmentation by Application:
Medical
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Vectorious
LivaNova
Phoenix Heart
Angel Medical Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insertable Heart Monitors market?
What factors are driving Insertable Heart Monitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insertable Heart Monitors market opportunities vary by end market size?
How does Insertable Heart Monitors break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Insertable Heart Monitors by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Insertable Heart Monitors by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
